v1
A Multicentre, Randomised, Double-Blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
NobleIDNI1P03W21R34S26
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260526/B00393D0)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors